Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-026606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01 | SRPT | Arif Bilal | Chief Tech Ops Off | F - Tax | $126.19 | -365 | 22.8K | -2% | -$46.1K |
| DM | 2024-03-05 | 2024-03-01 | SRPT | Arif Bilal | Chief Tech Ops Off | S - Sale | $128.84 | -2,000 | 27.3K | -7% | -$257.7K |
| D | 2024-03-05 | 2024-03-01 | SRPT | Arif Bilal | Chief Tech Ops Off | A - Grant | $0.00 | +6,000 | 28.8K | +26% | $0 |
| D | 2024-03-05 | 2024-03-01 | SRPT | Arif Bilal | Chief Tech Ops Off | A - Grant | $0.00 | -12.5K | 12.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | F | D | 114 | $126.19 | 26,722 | D | — | — | (F5) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. (F2) Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024. |
| 2 | Common | Common Stock | 2024-03-01 | S | D | 457 | $129.71 | 26,836 | D | — | — | (F4) Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards. |
| 3 | Common | Common Stock | 2024-03-01 | S | D | 1,543 | $128.58 | 27,293 | D | — | — | (F4) Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards. |
| 4 | Common | Common Stock | 2024-03-01 | A | A | 6,000 | $0.00 | 28,836 | D | — | — | (F3) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. |
| 5 | Common | Common Stock | 2024-03-01 | F | D | 251 | $126.19 | 22,836 | D | — | — | (F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. (F2) Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024. |
| 6 | Derivative | Stock Option (right to buy) | 2024-03-01 | A | D | 12,500 | $0.00 | 12,500 | D | $128.67 · 2025-03-01 to 2034-03-01 | 12,500 Common Stock | (F6) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. |